We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SL Green (SLG) Tops Off 34 Floors of 185 Broadway Property
Read MoreHide Full Article
SL Green Realty Corp. (SLG - Free Report) topped off the ground-up development of its 34-story mixed-use building — 185 Broadway — in Lower Manhattan. Amid the pandemic-led challenges, the construction was done on schedule and under budget. This is a notable feat for the company.
Moreover, with this property, SL Green brings the region’s first affordable housing development to be built through the Affordable New York Housing Program. For the development, it used the unutilized air rights that it purchased from the Metropolitan Transportation Authority (“MTA”), offering discretionary funding to the MTA.
Notably, the 260,000-square-foot property includes 17,000 square feet of retail, 26,000 square feet of commercial and 217,000 square feet of residential spaces, and is strategically located adjacent to the Fulton Transit Center. It will have two different entrance lobbies for the residential and commercial spaces.
The residential space consists of 209 rental units, of which 30% (63 units) will be affordable, consisting of studio, one-bedroom, two-bedroom and three-bedroom units. Moreover, the property will offer various amenities such as co-working space, a modern fitness center, club lounge, board room and large outdoor spaces.
Other than 185 Broadway, SL Green has made diligent efforts to strengthen its presence in the Manhattan region on the back of similar development initiatives. In fact, it completed the ground-up development of residential buildings — 180 Broadway and 33 Beekman — in close proximity and also broke ground on a build-to-suit development project for Pace University at 126 Nassau Street.
Such efforts are in line with the company’s mono-market strategy to focus on owning premium properties in the large and high-barrier to entry New York real estate market.
However, the geographic concentration of assets is concerning for SL Green. Notably, the majority of the company’s property holdings consists of commercial office properties situated in midtown Manhattan as well as retail properties and multifamily residential assets in New York City. Therefore, the performance of SL Green is susceptible to the condition of the New York economy, which is currently affected by the coronavirus pandemic.
Shares of this Zacks Ranks #4 (Sell) company have lost 38.6% compared with the industry’s decline of 7.1% over the past year.
Duke Realty Corporation’s Zacks Consensus Estimate for 2020 FFO per share has been revised 3.5% upward to $1.49 over the past two months. The company currently carries a Zacks Rank of 2.
Sabra Healthcare REIT, Inc.’s (SBRA - Free Report) FFO per share estimates for the ongoing year have been revised 1.2% upward to $1.74 over the past month. The company currently carries a Zacks Rank of 2.
Note: Anything related to earnings presented in this write-up represent funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
SL Green (SLG) Tops Off 34 Floors of 185 Broadway Property
SL Green Realty Corp. (SLG - Free Report) topped off the ground-up development of its 34-story mixed-use building — 185 Broadway — in Lower Manhattan. Amid the pandemic-led challenges, the construction was done on schedule and under budget. This is a notable feat for the company.
Moreover, with this property, SL Green brings the region’s first affordable housing development to be built through the Affordable New York Housing Program. For the development, it used the unutilized air rights that it purchased from the Metropolitan Transportation Authority (“MTA”), offering discretionary funding to the MTA.
Notably, the 260,000-square-foot property includes 17,000 square feet of retail, 26,000 square feet of commercial and 217,000 square feet of residential spaces, and is strategically located adjacent to the Fulton Transit Center. It will have two different entrance lobbies for the residential and commercial spaces.
The residential space consists of 209 rental units, of which 30% (63 units) will be affordable, consisting of studio, one-bedroom, two-bedroom and three-bedroom units. Moreover, the property will offer various amenities such as co-working space, a modern fitness center, club lounge, board room and large outdoor spaces.
Other than 185 Broadway, SL Green has made diligent efforts to strengthen its presence in the Manhattan region on the back of similar development initiatives. In fact, it completed the ground-up development of residential buildings — 180 Broadway and 33 Beekman — in close proximity and also broke ground on a build-to-suit development project for Pace University at 126 Nassau Street.
Such efforts are in line with the company’s mono-market strategy to focus on owning premium properties in the large and high-barrier to entry New York real estate market.
However, the geographic concentration of assets is concerning for SL Green. Notably, the majority of the company’s property holdings consists of commercial office properties situated in midtown Manhattan as well as retail properties and multifamily residential assets in New York City. Therefore, the performance of SL Green is susceptible to the condition of the New York economy, which is currently affected by the coronavirus pandemic.
Shares of this Zacks Ranks #4 (Sell) company have lost 38.6% compared with the industry’s decline of 7.1% over the past year.
Stocks to Consider
Iron Mountain Incorporated’s (IRM - Free Report) funds from operations (FFO) per share estimates for 2020 have been revised marginally upward to $2.17 over the past month. It currently carries a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Duke Realty Corporation’s Zacks Consensus Estimate for 2020 FFO per share has been revised 3.5% upward to $1.49 over the past two months. The company currently carries a Zacks Rank of 2.
Sabra Healthcare REIT, Inc.’s (SBRA - Free Report) FFO per share estimates for the ongoing year have been revised 1.2% upward to $1.74 over the past month. The company currently carries a Zacks Rank of 2.
Note: Anything related to earnings presented in this write-up represent funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>